These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 18626123

  • 1. Validity of self-reported adherence among injection drug users.
    Kerr T, Hogg RS, Yip B, Tyndall MW, Montaner J, Wood E.
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(4):157-9. PubMed ID: 18626123
    [Abstract] [Full Text] [Related]

  • 2. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [Abstract] [Full Text] [Related]

  • 3. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):188-94. PubMed ID: 16542797
    [Abstract] [Full Text] [Related]

  • 4. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill.
    Delgado J, Heath KV, Yip B, Marion S, Alfonso V, Montaner JS, O'Shaughnessy MV, Hogg RS.
    Antivir Ther; 2003 Oct 15; 8(5):471-8. PubMed ID: 14640395
    [Abstract] [Full Text] [Related]

  • 5. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS.
    Antivir Ther; 2004 Oct 15; 9(5):713-9. PubMed ID: 15535408
    [Abstract] [Full Text] [Related]

  • 6. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML, Jackson GL, Smith R, Wilson KH.
    Clin Ther; 2007 Apr 15; 29(4):711-6. PubMed ID: 17617294
    [Abstract] [Full Text] [Related]

  • 7. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK, Permana A, Read TR.
    HIV Med; 2005 Sep 15; 6(5):366-9. PubMed ID: 16156886
    [Abstract] [Full Text] [Related]

  • 8. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B, MANIF 2000 Study Group.
    Antivir Ther; 2005 Sep 15; 10(1):53-61. PubMed ID: 15751763
    [Abstract] [Full Text] [Related]

  • 9. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
    Grossberg R, Zhang Y, Gross R.
    J Clin Epidemiol; 2004 Oct 15; 57(10):1107-10. PubMed ID: 15528063
    [Abstract] [Full Text] [Related]

  • 10. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R, Langohr K, Tor J, Sanvisens A, Serra I, Rey-Joly C, Muñoz A.
    Clin Infect Dis; 2007 Aug 01; 45(3):370-6. PubMed ID: 17599317
    [Abstract] [Full Text] [Related]

  • 11. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P, Carrieri MP, Villes V, Dellamonica P, Poizot-Martin I, Ravaux I, Spire B, MANIF2000 cohort study group.
    Addiction; 2008 Nov 01; 103(11):1828-36. PubMed ID: 18778390
    [Abstract] [Full Text] [Related]

  • 12. Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: access, adherence and outcomes.
    Tyndall MW, McNally M, Lai C, Zhang R, Wood E, Kerr T, Montaner JG.
    Int J Drug Policy; 2007 Aug 01; 18(4):281-7. PubMed ID: 17689376
    [Abstract] [Full Text] [Related]

  • 13. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia.
    Lloyd-Smith E, Brodkin E, Wood E, Kerr T, Tyndall MW, Montaner JS, Hogg RS.
    AIDS; 2006 Feb 14; 20(3):445-50. PubMed ID: 16439879
    [Abstract] [Full Text] [Related]

  • 14. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
    Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, Cook JA, Goparaju L, Golub E, Richardson J, Wilson TE.
    Am J Drug Alcohol Abuse; 2008 Feb 14; 34(2):161-70. PubMed ID: 18293232
    [Abstract] [Full Text] [Related]

  • 15. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study.
    Small W, Wood E, Betteridge G, Montaner J, Kerr T.
    AIDS Care; 2009 Jun 14; 21(6):708-14. PubMed ID: 19806487
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
    Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD.
    Clin Infect Dis; 2004 Apr 15; 38(8):1167-74. PubMed ID: 15095224
    [Abstract] [Full Text] [Related]

  • 18. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E, Kerr T, Zhang R, Guillemi S, Palepu A, Hogg RS, Montaner JS.
    HIV Med; 2008 Aug 15; 9(7):503-7. PubMed ID: 18484977
    [Abstract] [Full Text] [Related]

  • 19. Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8).
    Carrieri MP, Villes V, Raffi F, Protopopescu C, Preau M, Salmon D, Taieb A, Lang JM, Verdon R, Chene G, Spire B, APROCO-COPILOTE ANRS CO-08 Study Group.
    Int J Drug Policy; 2007 Aug 15; 18(4):288-95. PubMed ID: 17689377
    [Abstract] [Full Text] [Related]

  • 20. Determinants of HAART discontinuation among injection drug users.
    Kerr T, Marshall A, Walsh J, Palepu A, Tyndall M, Montaner J, Hogg R, Wood E.
    AIDS Care; 2005 Jul 15; 17(5):539-49. PubMed ID: 16036240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.